The global ziprasidone market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Ziprasidone is prescribed by doctors as a mood stabilizer for the maintenance treatment of bipolar disorders. Ziprasidone drug is also used to treat the symptoms of schizophrenia disorder. The market is growing due to the increased prevalence of bipolar disorder disease as well as rising initiatives by government institutions to increase awareness among the population. According to the Institute for Health Metrics and Evaluation, the prevalence of bipolar disorder varies from 0.3 to 1.2 by country. In 2017, almost 46 million people in the world had bipolar disorder with men holding 48% share and females holding 52% share globally.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-ziprasidone/92755/
National Alliance on Mental Illness, an estimation of 1 in every 5 adults in the US experiences mental illness every year. According to World Health Organization, bipolar disorder is considered the sixth leading cause of disability in the world. According to the Nation Institute of Medical Health, bipolar disorder almost reduces 9.2 years of expected life span and almost one in every five bipolar disorder patients commits suicide. Hence, the rise in the cases of bipolar disorder and the increasing need to manage the disease effectively is boosting the growth of the ziprasidone market growth in the forecast period.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape– Reddy’s Laboratories Ltd., Pfizer Inc., Lupin, Mylan N.V., Aurobindo Pharma, and WOCKHARDT among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Ziprasidone Market Report by Segment
By Type
- Oral capsule
- Injection
By Indication
- Hospital
- Drug Store
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on Global market Post
Global market Post is not responsible for any content included in this release.
